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Medical and scientific assessments as the basis for prioritization and resource allocation for new drug treatment - experiences from five years of systematic workIn this study, the process for introduction of new drug treatment in Region Västra Götaland (second largest region in Sweden encompassing 1.6 million inhabitants, 17% of all inhabitants in Sweden) is described. A working group, consisting of persons with relevant expertise and declared conflicts of interest, contributes with medical and scientific assessments as the basis for prioritization and resource allocation. In 2011-2015, 111 new drug treatments were nominated by healthcare representatives, 84 fulfilled the criteria for assessments by the working group, and 57 (68%) were deemed to have high/medium high priority to receive introduction financing according to the severity of disease, the benefit/risk balance, and the level of evidence. When analyzing subsequent costs for new drug treatments for which data could be obtained and specifically evaluated, the results indicate that the process can contribute to rational use of medicines.